{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:42:39Z","timestamp":1771267359024,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2004,9,15]],"date-time":"2004-09-15T00:00:00Z","timestamp":1095206400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1007\/s00228-004-0811-7","type":"journal-article","created":{"date-parts":[[2004,9,14]],"date-time":"2004-09-14T14:45:07Z","timestamp":1095173107000},"page":"541-545","source":"Crossref","is-referenced-by-count":26,"title":["Electrocardiogram and cardiovascular changes in thioridazine and chlorpromazine poisoning"],"prefix":"10.1007","volume":"60","author":[{"given":"E. M.","family":"Strachan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. N.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,9,15]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","volume":"350","author":"DM Roden","year":"2004","unstructured":"Roden DM (2004) Drug induced prolongation of the QT interval. N Engl J Med 350:1013?1022","journal-title":"N Engl J Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","volume":"355","author":"JG Reilly","year":"2000","unstructured":"Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SHL (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355:1048?1052","journal-title":"Lancet"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2165\/00003495-200262110-00006","volume":"62","author":"PM Haddad","year":"2002","unstructured":"Haddad PM, Anderson IM (2002) Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 62:1649?1671","journal-title":"Drugs"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1034\/j.1600-0447.2003.02078.x","volume":"107","author":"DM Taylor","year":"2003","unstructured":"Taylor DM (2003) Antipsychotics and QT prolongation. Acta Psychiatr Scand 107:85?95","journal-title":"Acta Psychiatr Scand"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1365-2125.2003.01792.x","volume":"55","author":"DN Bateman","year":"2003","unstructured":"Bateman DN, Good AM, Afshari R, Kelly CA (2003) Effects of licence change on prescribing and poisons enquires for antipsychotic agents in England and Scotland. Br J Clin Pharmacol 55:596?693","journal-title":"Br J Clin Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/bmj.324.7352.1519","volume":"324","author":"SJC Davies","year":"2002","unstructured":"Davies SJC, Cooke LB, Moore AG, Potokar J (2002) Discontinuation of thioridazine in patients with learning disabilities: balancing cardiovascular toxicity with adverse consequences of changing drugs. Br Med J 324:1519?1521","journal-title":"Br Med J"},{"issue":"suppl2","key":"CR7","first-page":"35","volume":"62","author":"J Czekalla","year":"2001","unstructured":"Czekalla J, Kollack-Walker S, Beasley CM (2001) Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychotics. J Clin Psychiatry 62(suppl2):35?40","journal-title":"J Clin Psychiatry"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/j.1875-9114.1994.tb02816.x","volume":"14","author":"DT Hulisz","year":"1994","unstructured":"Hulisz DT, Dasa SL, Black LD, Heiselman DE (1994) Complete heart block and torsade de pointes associated with thioridazine poisoning. Pharmacotherapy 14:239?245","journal-title":"Pharmacotherapy"},{"key":"CR9","first-page":"62","volume":"26","author":"C Gury","year":"2000","unstructured":"Gury C, Canceil O, Iaria P (2000) Antipsychotic drugs and cardiovascular safety: current study of prolonged QT interval and risk of ventricular arrhythmia. Encephale 26:62?72","journal-title":"Encephale"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/oxfordjournals.eurheartj.a015357","volume":"18","author":"M Stramba-Badiale","year":"1997","unstructured":"Stramba-Badiale M, Locati EH, Martinelli A, Courville J, Schwartz PJ (1997) Gender and the relationship between ventricular repolarisation and the cardiac cycle length during 24-h Holter recordings. Eur Heart J 18:1000?1006","journal-title":"Eur Heart J"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002280050714","volume":"56","author":"F Ponti De","year":"2000","unstructured":"De Ponti F, Poluzzi E, Montanaro N (2000) Qt-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience. Eur J Clin Pharmacol 56:1?18","journal-title":"Eur J Clin Pharmacol"},{"key":"CR12","first-page":"637","volume":"276","author":"A Bril","year":"1996","unstructured":"Bril A, Gout B, Bonhomme M, Landais L, Faivre J, Linee P, Poyser RH, Ruffolo RR (1996) Combined potassium and calcium channel blocking activities as a basis for arythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872. J Pharmacol Exp Ther 276:637?646","journal-title":"J Pharmacol Exp Ther"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/14656566.3.5.479","volume":"3","author":"PJ Goodnick","year":"2002","unstructured":"Goodnick PJ, Parra F, Jerry J (2002) Psychotropic drugs and the ECG: focus on the QTc interval. Expert Opin Pharmacother 3:479?498","journal-title":"Expert Opin Pharmacother"},{"key":"CR14","first-page":"4","volume":"27","author":"MCA\/CSM","year":"2001","unstructured":"MCA\/CSM (2001) QTc prolongation with antipsychotics. Curr Probl 27:4","journal-title":"Curr Probl"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0447.1996.tb10653.x","volume":"93","author":"JP Warner","year":"1996","unstructured":"Warner JP, Barnes TR, Henry JA, (1996) Electrocardiographic changes in patients receiving neuroleptic medication. Acta Psychiatr Scand 93:311?313","journal-title":"Acta Psychiatr Scand"},{"key":"CR16","first-page":"416","volume":"53","author":"AM Good","year":"2002","unstructured":"Good AM, Strachan F, Oliver J, Kelly CA, Bateman DN (2002) Licensing decisions and TOXBASE\u00ae?evaluating the effect of restricted indications for thioridazine on its use in acute overdose. J Clin Pharmacol 53:416?417","journal-title":"J Clin Pharmacol"},{"key":"CR17","first-page":"1261","volume":"288","author":"B Drolet","year":"1999","unstructured":"Drolet B, Vincent F, Rail J, Chahine M, Deschenes D, Nadeau S, Khalifa M, Hamelin BA, Turgeon J (1999) Thioridazine lengthens repolarisation of cardiac ventricular myocytes by blocking the delayed rectifier potassium current. J Pharmacol Exp Ther 288:1261?1268","journal-title":"J Pharmacol Exp Ther"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0002-9149(76)90316-7","volume":"37","author":"NO Fowler","year":"1976","unstructured":"Fowler NO, McCall D, Chou TC, Holmes JC, Hanenson IB (1976) Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Am J Cardiol 37:223?230","journal-title":"Am J Cardiol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0009-9236(96)90150-2","volume":"60","author":"K Hartington-Go","year":"1996","unstructured":"Hartington-Go K, Bateman DN, Nyberg G, Martensson E, Thomas SHL (1996) Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans. Clin Pharmacol Ther 60:543?553","journal-title":"Clin Pharmacol Ther"},{"key":"CR20","first-page":"127","volume":"34","author":"P Hale","year":"1996","unstructured":"Hale P, Poklis A (1996) Thioridazine cardiotoxicity. Clin Toxicol 34:127?128","journal-title":"Clin Toxicol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1192\/bjp.180.6.515","volume":"180","author":"JG Reilly","year":"2002","unstructured":"Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SHL (2002) Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiatry 180:515?522","journal-title":"Br J Psychiatry"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/15563659509017984","volume":"33","author":"NA Buckley","year":"1995","unstructured":"Buckley NA, Whyte IM, Dawson AH (1995) Cardiotoxicity more common in thioridazine overdose than with other neuroleptics. J Toxicol Clin Toxicol 33:199?204","journal-title":"J Toxicol Clin Toxicol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1192\/bjp.163.2.183","volume":"163","author":"PB Mortensen","year":"1993","unstructured":"Mortensen PB, Juel K (1993) Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry 163:183?189","journal-title":"Br J Psychiatry"},{"key":"CR24","first-page":"619","volume":"24","author":"L Belardinelli","year":"2003","unstructured":"Belardinelli L, Antzelevitch C, Vos MA (2003) Assessing predictors of drug induced torsade de pointes. TIPS 24:619?625","journal-title":"TIPS"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0811-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-004-0811-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0811-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T10:16:20Z","timestamp":1705227380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-004-0811-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,15]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1007\/s00228-004-0811-7","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,15]]}}}